These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 12637702)
21. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke. Pongrácz E Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349 [TBL] [Abstract][Full Text] [Related]
22. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes. Małek ŁA; Spiewak M; Filipiak KJ; Grabowski M; Szpotańska M; Rosiak M; Główczyńska R; Imiela T; Huczek Z; Opolski G Kardiol Pol; 2007 Jan; 65(1):40-5; discussion 46. PubMed ID: 17295159 [TBL] [Abstract][Full Text] [Related]
23. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388 [TBL] [Abstract][Full Text] [Related]
25. Platelet Surface CD62p and Serum Vitamin D Levels are Associated with Clopidogrel Resistance in Chinese Patients with Ischemic Stroke. Lu BC; Shi XJ; Liang L; Dong N; Liu ZZ J Stroke Cerebrovasc Dis; 2019 May; 28(5):1323-1328. PubMed ID: 30795966 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease. Meyer A; Weithaeuser A; Steffens D; Bobbert P; Hassanein A; Ayral Y; Schultheiss HP; Rauch U Cardiovasc Revasc Med; 2016; 17(3):169-75. PubMed ID: 27157293 [TBL] [Abstract][Full Text] [Related]
27. Residual platelet reactivity after aspirin and clopidogrel treatment predicts 2-year major cardiovascular events in patients undergoing percutaneous coronary intervention. Chiu FC; Wang TD; Lee JK; Shih FY; Lin JW; Huang CH; Chen WJ; Chen MF Eur J Intern Med; 2011 Oct; 22(5):471-7. PubMed ID: 21925055 [TBL] [Abstract][Full Text] [Related]
28. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161 [TBL] [Abstract][Full Text] [Related]
29. Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patients. Serebruany VL; Malinin AI; Atar D Cardiology; 2007; 107(4):307-12. PubMed ID: 17264511 [TBL] [Abstract][Full Text] [Related]
30. Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke. Sternberg Z; Chichelli T; Sternberg D; Sawyer R; Ching M; Janicke D; Ambrus JL; Yu J; Munschauer F J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):327-34. PubMed ID: 26586373 [TBL] [Abstract][Full Text] [Related]
31. Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. Qiu LN; Sun Y; Wang L; Han RF; Xia XS; Liu J; Li X Eur J Pharmacol; 2015 Jan; 747():29-35. PubMed ID: 25489921 [TBL] [Abstract][Full Text] [Related]
32. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]
33. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392 [TBL] [Abstract][Full Text] [Related]
34. Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke. Zhao L; Fletcher S; Weaver C; Leonardi-Bee J; May J; Fox S; Willmot M; Heptinstal S; Bath P Thromb Haemost; 2005 Mar; 93(3):527-34. PubMed ID: 15735805 [TBL] [Abstract][Full Text] [Related]
35. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone. Hong KS; Lee SH; Kim EG; Cho KH; Chang DI; Rha JH; Bae HJ; Lee KB; Kim DE; Park JM; Kim HY; Cha JK; Yu KH; Lee YS; Lee SJ; Choi JC; Cho YJ; Kwon SU; Kim GM; Sohn SI; Park KY; Kang DW; Sohn CH; Lee J; Yoon BW; Stroke; 2016 Sep; 47(9):2323-30. PubMed ID: 27418597 [TBL] [Abstract][Full Text] [Related]
36. Course of platelet activation markers after ischemic stroke. Marquardt L; Ruf A; Mansmann U; Winter R; Schuler M; Buggle F; Mayer H; Grau AJ Stroke; 2002 Nov; 33(11):2570-4. PubMed ID: 12411644 [TBL] [Abstract][Full Text] [Related]
37. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R; Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679 [TBL] [Abstract][Full Text] [Related]